Puma's (PBYI) Alisertib Gets FDA's Orphan Drug Tag for SCLC | Nasdaq
Puma Biotechnology, Inc. (PBYI) Stock Price, Quote & News - Stock Analysis
Conspiracy Theory: Did Puma Biotech Exec Resign Because of Bad News Ahead? | BioSpace
Here's Why You May Invest in Puma Biotechnology (PBYI) Stock
Puma Biotechnology (NasdaqGS:PBYI) Stock Forecast & Analyst Predictions - Simply Wall St
Why Puma Biotechnology (PBYI) Stock Is Surging Today - TheStreet
Puma Biotechnology, Inc. Announces FDA Clearance of IND for Alisertib in Small Cell Lung Cancer -August 08, 2023 at 08:30 am EDT | MarketScreener
Puma Biotechnology | $PBYI Stock | Shares Climb Up as Company Announced FDA Approval for NERLYNX - Warrior Trading News
Puma Biotechnology Stock Quote | Stock Price for PBYI | FinancialContent Business Page
pbyi-10k_20171231.htm
Puma Biotechnology: Finding Bullish Indications At The End Of 2019 (NASDAQ:PBYI) | Seeking Alpha
Earnings Flash (PBYI) PUMA BIOTECHNOLOGY Posts Q3 EPS $0.17, vs. Street Est of $0.14 -November 02, 2023 at 04:17 pm EDT | MarketScreener
Here's Why Puma Biotechnology, Inc. (PBYI) is Down on Tuesday
Puma Biotechnology (PBYI) Stock Builds on Friday's 40% Move
Puma Biotechnology Reports Fourth Quarter and Full Year Financial Results | Business Wire
Puma Biotech (PBYI) Q4 Loss Wider Than Expected, Sales Top | Nasdaq
Puma Biotechnology Crashed After Lagging More Bullish Views For Breast Cancer Drug Nerlynx | Stock News & Stock Market Analysis - IBD
Articles about Puma Biotechnology
Puma Biotechnology Inc (PBYI) Stock Price & Performance 2023
Puma Biotech (PBYI) Inks Agreement for Takeda's Alisertib - September 21, 2022 - Zacks.com
Why Shares in Puma Biotechnology Inc. Are Plunging | The Motley Fool
A New Drug on the Horizon for HER2 Breast Cancer Patients | Avise Analytics
Puma Biotechnology Inc (NASDAQ:PBYI) Share Price | RNS News, Quotes, & Charts | PBYI
Puma Biotechnology
Puma Biotechnology Inc (PBYI) Stock: What Does the Chart Say Tuesday?
